ASML Holding
US.ASML
1,714.88
+68.69
+4.17%
ASML Holding
1,714.88
+68.69
+4.17%
Collector offline (last heartbeat: 15858s ago)
· 2026-09-04 20:02
Pre-market
1,677.72
+1.92%
After-hours
1,711.00
-0.23%
Overnight
1,678.06
+1.94%
Revenue annual, last 8 years
Latest year +15.58% YoY
Margins
- Gross margin
- 52.83%
- Operating margin
- 34.60%
- Net margin
- 29.42%
Key ratios & quality
- Enterprise value
- 649.75B
- PEG ratio
- 2.74
- Altman Z-Score
- 14.79
PEG uses trailing P/E against the 3-year net income growth rate (19.55%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
✦ AI Financial Health how this is computed
Good
- Altman Z-Score is 14.79, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.94B | 11.82B | 13.98B | 18.61B | 21.17B | 27.56B | 28.26B | 32.67B |
| Gross profit | 5.03B | 5.28B | 6.80B | 9.81B | 10.70B | 14.14B | 14.49B | 17.26B |
| Selling & admin expenses | 488.00M | 520.50M | 544.90M | 725.60M | 945.90M | 1.11B | 1.17B | 1.26B |
| Research & development | 1.58B | 1.97B | 2.20B | 2.55B | 3.25B | 3.98B | 4.30B | 4.70B |
| Operating profit | 2.97B | 2.79B | 4.05B | 6.54B | 6.50B | 9.04B | 9.02B | 11.30B |
| Pretax profit | 2.94B | 2.77B | 4.02B | 6.71B | 6.46B | 9.08B | 9.04B | 11.41B |
| Tax | 351.60M | 191.70M | 551.50M | 1.02B | 969.90M | 1.44B | 1.68B | 2.01B |
| Net profit | 2.59B | 2.59B | 3.55B | 5.88B | 5.62B | 7.84B | 7.57B | 9.61B |
| Basic EPS | 6 | 6 | 8 | 14 | 14 | 20 | 19 | 25 |
| Diluted EPS | 6.08 | 6.15 | 8.48 | 14.34 | 14.13 | 19.89 | 19.24 | 24.71 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 7.74B | 7.69B | 7.52B | 9.72B | 8.77B | 9.33B |
| Gross profit | 4.18B | 4.13B | 3.88B | 5.07B | 4.65B | 5.04B |
| Selling & admin expenses | 280.70M | 298.70M | 303.20M | 375.20M | 302.30M | 302.70M |
| Research & development | 1.16B | 1.17B | 1.11B | 1.26B | 1.18B | 1.28B |
| Operating profit | 2.74B | 2.66B | 2.47B | 3.43B | 3.16B | 3.46B |
| Pretax profit | 2.79B | 2.69B | 2.49B | 3.44B | 3.20B | 3.49B |
| Tax | 465.10M | 487.40M | 442.20M | 618.70M | 546.60M | 609.60M |
| Net profit | 2.36B | 2.29B | 2.12B | 2.84B | 2.76B | 2.92B |
| Basic EPS | 6 | 6 | 5 | 7 | 7 | 8 |
| Diluted EPS | 6.00 | 5.90 | 5.48 | 7.34 | 7.15 | 7.58 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 10.53B | 12.13B | 15.93B | 18.19B | 23.06B | 24.39B | 30.74B | 30.62B |
| Cash & ST investments | 4.03B | 4.72B | 7.35B | 7.59B | 7.38B | 7.01B | 12.74B | 13.32B |
| Inventory | 3.44B | 3.81B | 4.57B | 5.18B | 7.20B | 8.85B | 10.89B | 11.43B |
| Total assets | 20.14B | 22.63B | 27.27B | 30.23B | 36.30B | 39.96B | 48.59B | 50.57B |
| Total current liabilities | 3.79B | 4.69B | 6.60B | 12.30B | 17.98B | 16.27B | 20.05B | 24.26B |
| Short-term debt | -- | -- | 15.40M | 509.10M | 746.20M | 100.00K | 1.01B | 1.68B |
| Long-term debt | 3.03B | 3.11B | 4.66B | 4.08B | 3.51B | 4.63B | 3.68B | 2.71B |
| Total liabilities | 8,495,900,000.00 | 10,037,400,000.00 | 13,402,000,000.00 | 20,090,400,000.00 | 27,489,600,000.00 | 26,505,100,000.00 | 30,112,800,000.00 | 30,954,400,000.00 |
| Total equity | 11.64B | 12.59B | 13.87B | 10.14B | 8.81B | 13.45B | 18.48B | 19.61B |
| Retained earnings | 9.20B | 9.52B | 10.73B | 8.32B | 9.05B | 12.38B | 14.41B | 17.59B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 27.52B | 26.71B | 25.15B | 30.62B | 27.58B | 29.55B |
| Cash & ST investments | 9.10B | 7.25B | 5.13B | 13.32B | 8.38B | 7.58B |
| Inventory | 11.02B | 11.58B | 11.76B | 11.43B | 11.71B | 11.74B |
| Total assets | 45.48B | 44.85B | 45.10B | 50.57B | 48.06B | 50.21B |
| Total current liabilities | 18.12B | 18.62B | 19.22B | 24.26B | 20.29B | 22.15B |
| Short-term debt | -- | -- | -- | 1.68B | -- | -- |
| Long-term debt | 3.68B | 3.70B | 2.70B | 2.71B | 2.71B | 1.98B |
| Total liabilities | 27,978,100,000.00 | 27,230,900,000.00 | 26,103,600,000.00 | 30,954,400,000.00 | 27,231,000,000.00 | 28,389,400,000.00 |
| Total equity | 17.50B | 17.62B | 18.99B | 19.61B | 20.83B | 21.83B |
| Retained earnings | -- | -- | -- | 17.59B | -- | -- |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.07B | 3.28B | 4.63B | 10.85B | 8.49B | 5.44B | 11.17B | 12.66B |
| Depreciation & amortization | 422.70M | 448.50M | 490.80M | 471.00M | 583.60M | 739.80M | 918.60M | 1.03B |
| Free cash flow | 2.46B | 2.39B | 3.63B | 9.91B | 7.17B | 3.25B | 9.08B | 11.03B |
| Dividends paid | -597.10M | -1.33B | -1.07B | -1.37B | -2.56B | -2.35B | -2.45B | -2.55B |
| Stock buybacks / issuance | -1.12B | -382.80M | -1.17B | -8.51B | -4.56B | -900.60M | -376.00M | -5.81B |
| Ending cash balance | 3.12B | 3.53B | 6.05B | 6.95B | 7.27B | 7.00B | 12.74B | 12.92B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -58.60M | 747.70M | 559.10M | 11.41B | -- | -- |
| Depreciation & amortization | 241.30M | 254.90M | 274.60M | 255.20M | -- | -- |
| Free cash flow | -475.10M | 318.80M | 243.70M | 10.94B | -- | -- |
| Dividends paid | -597.20M | -714.40M | -619.60M | -619.20M | -- | -- |
| Stock buybacks / issuance | -2.55B | -1.45B | -136.90M | -1.67B | -- | -- |
| Ending cash balance | 9.10B | 7.24B | 5.13B | 12.92B | -- | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE % | 23.23 | 21.39 | 26.86 | 49.01 | 59.35 | 70.42 | 47.43 | 50.46 |
| ROA % | 13.52 | 12.12 | 14.24 | 20.46 | 16.91 | 20.56 | 17.10 | 19.38 |
| ROIC % | 18.29 | 17.07 | 20.75 | 35.60 | 40.74 | 50.10 | 36.63 | 40.38 |
| 5-year avg ROE % | 18.87 | 19.83 | 21.71 | 28.09 | 35.95 | 45.41 | 50.62 | 55.33 |
| EBIT margin % | 27.10 | 23.61 | 28.98 | 36.32 | 30.78 | 33.51 | 32.57 | 35.28 |
| FCF / sales % | 22.51 | 20.22 | 25.95 | 53.22 | 33.85 | 11.78 | 32.14 | 33.76 |
| Current ratio | 2.78 | 2.58 | 2.41 | 1.48 | 1.28 | 1.50 | 1.53 | 1.26 |
| Quick ratio | 1.70 | 1.61 | 1.62 | 0.99 | 0.80 | 0.88 | 0.91 | 0.74 |
| Debt / assets | 26.00 | 24.68 | 33.74 | 45.21 | 48.35 | 34.43 | 25.37 | 22.39 |
| LT debt / equity | 26.00 | 24.68 | 33.63 | 40.19 | 39.89 | 34.43 | 19.90 | 13.81 |
| Interest coverage | -- | -- | -- | 123.81 | 107.19 | 60.49 | 56.61 | 97.42 |
| Revenue CAGR (3Y) % | 20.29 | 19.80 | 15.97 | 19.36 | 21.45 | 25.39 | 14.94 | 15.55 |
| Net income CAGR (3Y) % | 23.16 | 18.50 | 19.80 | 31.43 | 29.46 | 30.17 | 8.77 | 19.55 |
| FCF CAGR (3Y) % | 14.23 | 21.25 | 35.42 | 59.02 | 44.20 | -3.62 | -2.85 | 15.44 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE % | 55.62 | 58.32 | 53.85 | 50.46 | 52.24 | 49.76 |
| ROA % | 20.59 | 22.03 | 21.79 | 19.38 | 21.41 | 20.65 |
| ROIC % | 43.97 | 46.08 | 44.49 | 40.38 | 44.78 | 43.12 |
| 5-year avg ROE % | -- | -- | -- | -- | -- | -- |
| EBIT margin % | 34.35 | 35.59 | 35.42 | 35.28 | 35.45 | 33.26 |
| FCF / sales % | 30.23 | 28.66 | 27.71 | 33.76 | 26.40 | 28.00 |
| Current ratio | 1.52 | 1.43 | 1.31 | 1.26 | 1.36 | 1.33 |
| Quick ratio | 0.81 | 0.71 | 0.61 | 0.74 | 0.70 | 0.73 |
| Debt / assets | 21.03 | 20.99 | 14.24 | 22.39 | 12.99 | 9.09 |
| LT debt / equity | 21.03 | 20.99 | 14.24 | 13.81 | 12.99 | 9.09 |
| Interest coverage | -- | 81.23 | -- | 97.42 | -- | 118.22 |
| Revenue CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Holistic lithography solution provider, for development, production, marketing, sales, upgrading and100.00%
Region
China29.14%
Taiwan25.52%
South Korea24.98%
United States12.52%
Japan4.35%
Singapore1.86%
EMEA1.60%
Quote time 2026-09-04 20:02:40 · For reference only, not investment advice.